High intensity focused ultrasound (HIFU) therapy for local treatment of hepatocellular carcinoma: role of partial rib resection.

OBJECTIVE It has long been known that high intensity focused ultrasound (HIFU) can kill tissue through coagulative necrosis. However, it is only in recent years that practical clinical applications are becoming possible. Since the ribs have strong reflections to ultrasonic beams, they may affect the deposition of ultrasound energy, decreasing the efficacy of HIFU treatment and increasing the chance of adverse events when the intra-abdominal tumours concealed by ribs are treated. The aim of this study was to evaluate the influence of partial rib resection on the efficacy and safety of HIFU treatment. METHODS This prospective study was approved by the ethics committee at Chongqing University of Medical Sciences. An informed consent form was obtained from each patient and family member. A total of 16 patients with hepatocellular carcinoma (HCC), consisting of 13 males and 3 females, were studied. All patients had the successful HIFU treatment. To create a better acoustic pathway for HIFU treatment, all of the 16 patients had the ribs that shield the tumour mass to be removed. Magnetic resonance imaging (MRI) was used to evaluate the efficacy of HIFU treatment. RESULTS Sixteen cases had 23 nodules, including 12 cases with a single nodule, 1 case with 2 nodules, 3 cases with 3 nodules. The mean diameter of tumours was 7.0+/-2.1 cm (5-10 cm). According to TNM classification, 9 patients were diagnosed as stage II, 4 patients were stage III, and 3 patients were stage IV. Follow-up imaging showed an absence of tumour blood supply and shrinkage of all treated lesions. The survival rates at 1, 2, 3, 4, and 5 years were 100%, 83.3%, 69.4%, 55.6%, and 55.6%, respectively. No serious complications were observed in the patients treated with HIFU. CONCLUSION Partial rib resection can create a better acoustic pathway of HIFU therapy. Even though it is an invasive treatment, this measure offers patients an improved prospect of complete tumour ablation when no other treatment is available.

[1]  P. McCormack,et al.  Use of prosthetic materials in chest-wall reconstruction. Assets and liabilities. , 1989, The Surgical clinics of North America.

[2]  Ian Rivens,et al.  The use of a segmented transducer for rib sparing in HIFU treatments. , 2006, Ultrasound in medicine & biology.

[3]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[4]  A. E. Miller,et al.  A NEW METHOD FOR THE GENERATION AND USE OF FOCUSED ULTRASOUND IN EXPERIMENTAL BIOLOGY , 1942, The Journal of general physiology.

[5]  J. Pignon,et al.  Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. , 1998, Journal of hepatology.

[6]  Wen-Zhi Chen,et al.  Extracorporeal high intensity focused ultrasound ablation in the treatment of 1038 patients with solid carcinomas in China: an overview. , 2004, Ultrasonics sonochemistry.

[7]  D. Chan,et al.  Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  T. Livraghi,et al.  Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia. , 1993, AJR. American journal of roentgenology.

[9]  Diagnosis and treatment of hepatocellular carcinoma , 1997 .

[10]  Win-Li Lin,et al.  Feasibility of transrib focused ultrasound thermal ablation for liver tumors using a spherically curved 2D array: a numerical study. , 2007, Medical physics.

[11]  P. Dartevelle,et al.  Radical resection of radiation-induced sarcoma of the chest wall: report of 15 cases. , 1997, The Annals of thoracic surgery.

[12]  Wen-zhi Chen,et al.  Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. , 2004, Ultrasound in medicine & biology.

[13]  M. Uetani,et al.  Percutaneous Radiofrequency Ablation and Transcatheter Arterial Chemoembolization for Hypervascular Hepatocellular Carcinoma: Rate and Risk Factors for Local Recurrence , 2007, CardioVascular and Interventional Radiology.

[14]  Kenji Ikeda,et al.  Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the cox proportional hazard model , 1991, Cancer.

[15]  Elizabeth A Stewart,et al.  Magnetic Resonance-Guided Focused Ultrasound Surgery , 2010, Seminars in reproductive medicine.

[16]  M. Makuuchi,et al.  Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. , 2006, Gastroenterology.

[17]  Wen-Zhi Chen,et al.  Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. , 2005, Radiology.

[18]  J. Bruix,et al.  Chemoembolization for hepatocellular carcinoma. , 2004, Gastroenterology.

[19]  R. Sanders,et al.  Subclavian vein obstruction without thrombosis. , 2005, Journal of vascular surgery.

[20]  D. Kopelman,et al.  Magnetic resonance guided focused ultrasound surgery. Ablation of soft tissue at bone–muscle interface in a porcine model , 2008, European journal of clinical investigation.

[21]  J. Bruix,et al.  Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution , 1998, Hepatology.

[22]  Ramon Planas,et al.  Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial , 2002, The Lancet.

[23]  W J FRY,et al.  Production of focal destructive lesions in the central nervous system with ultrasound. , 1954, Journal of neurosurgery.

[24]  K. Hynynen,et al.  Trans-skull ultrasound therapy: the feasibility of using image-derived skull thickness information to correct the phase distortion , 1999, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.

[25]  M. Sakuraba,et al.  Surgical treatment of tuberculous abscess in the chest wall. , 2005, The Annals of thoracic surgery.

[26]  K. Hayashi,et al.  Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation , 2003, Journal of Gastroenterology.

[27]  G. Gandini,et al.  Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC) , 2006, European Radiology.